Search research articles
Contact Us
Filters
Showing results (981-990 of 1,044) with videos related to
Page
of 105
Sort By:
Blood
|
January 22, 2025
IL-1R1 and IL-18 signals regulate mesenchymal stromal cells in an aged murine model of myelodysplastic syndromes
Yuko Kawano, Hiroki Kawano, Mark W LaMere, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V
|
May 2, 2016
Human skin penetration and local effects of topical nano zinc oxide after occlusion and barrier impairment
V R Leite-Silva, W Y Sanchez, H Studier, et al.
Journal of Geriatric Oncology
|
December 24, 2021
Protocol for a pilot randomized controlled trial of a mobile health exercise intervention for older patients with myeloid neoplasms (GO-EXCAP 2)
Kah Poh Loh, Chandrika Sanapala, Michelle Janelsins, et al.
Malaria Journal
|
October 12, 2011
In vitro anti-plasmodial activity of Dicoma anomala subsp. gerrardii (Asteraceae): identification of its main active constituent, structure-activity relationship studies and gene expression profiling
John V W Becker, Marina M van der Merwe, Anna C van Brummelen, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 17, 2007
Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin
Tesfaye Biftu, Giovanna Scapin, Suresh Singh, et al.
Nature
|
June 10, 2016
Environmental Breviatea harbour mutualistic Arcobacter epibionts
Emmo Hamann, Harald Gruber-Vodicka, Manuel Kleiner, et al.
Biochemistry
|
October 1, 2003
The structural basis for the selectivity of benzotriazole inhibitors of PTP1B
Giovanna Scapin, Sangita B Patel, Joseph W Becker, et al.
British Journal of Cancer
|
December 17, 2003
Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer
R Repp, H H van Ojik, T Valerius, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
PSP-0119: Targeted IRAK4 Degradation as a Novel Therapeutic Strategy for FLT3-Mutant AML
Negar Khazan, Cameron Wa Snyder, Chandhana Ravi, et al.
Blood
|
July 17, 2016
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression
Tzu-Chieh Ho, Mark LaMere, Brett M Stevens, et al.
Page
of 105
Search research articles
Search
Showing results (981-990 of 1,044) with videos related to
Sort By:
Page
of 105
Blood
|
January 22, 2025
IL-1R1 and IL-18 signals regulate mesenchymal stromal cells in an aged murine model of myelodysplastic syndromes
Yuko Kawano, Hiroki Kawano, Mark W LaMere, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V
|
May 2, 2016
Human skin penetration and local effects of topical nano zinc oxide after occlusion and barrier impairment
V R Leite-Silva, W Y Sanchez, H Studier, et al.
Journal of Geriatric Oncology
|
December 24, 2021
Protocol for a pilot randomized controlled trial of a mobile health exercise intervention for older patients with myeloid neoplasms (GO-EXCAP 2)
Kah Poh Loh, Chandrika Sanapala, Michelle Janelsins, et al.
Malaria Journal
|
October 12, 2011
In vitro anti-plasmodial activity of Dicoma anomala subsp. gerrardii (Asteraceae): identification of its main active constituent, structure-activity relationship studies and gene expression profiling
John V W Becker, Marina M van der Merwe, Anna C van Brummelen, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 17, 2007
Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin
Tesfaye Biftu, Giovanna Scapin, Suresh Singh, et al.
Nature
|
June 10, 2016
Environmental Breviatea harbour mutualistic Arcobacter epibionts
Emmo Hamann, Harald Gruber-Vodicka, Manuel Kleiner, et al.
Biochemistry
|
October 1, 2003
The structural basis for the selectivity of benzotriazole inhibitors of PTP1B
Giovanna Scapin, Sangita B Patel, Joseph W Becker, et al.
British Journal of Cancer
|
December 17, 2003
Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer
R Repp, H H van Ojik, T Valerius, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
PSP-0119: Targeted IRAK4 Degradation as a Novel Therapeutic Strategy for FLT3-Mutant AML
Negar Khazan, Cameron Wa Snyder, Chandhana Ravi, et al.
Blood
|
July 17, 2016
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression
Tzu-Chieh Ho, Mark LaMere, Brett M Stevens, et al.
Page
of 105